Strategic Partnership Agreement Integrates Sonrai's AI Data Management Platform, Sonrai Discovery, with SmartLabs' Advanced Laboratory Infrastructure BOSTON, Aug. 28, 2025 /PRNewswire/ -- SmartLabs and…
SAN FRANCISCO, CA / ACCESS Newswire / August 28, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused…
CHICAGO, IL / ACCESS Newswire / August 28, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for…
Independent Benchmarking Across 13 EU Countries and the UK Reveals Vendor Readiness and Country Gaps Ahead of EHDS Enforcement LONDON,…
In vitro findings reveal Telomir-1's dual action: targeting DNA methylation switches and cutting into the Wnt "fuel line" that drives…
VANCOUVER, BC / ACCESS Newswire / August 28, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or "the Company") pleased to…
Ramat Gan, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company…
BERKELEY HEIGHTS, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (“CorMedix”) (Nasdaq: CRMD), a biopharmaceutical company focused on developing…
DOYLESTOWN, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company…
HOUSTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company…